Arlington Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $165K | Sell |
650
-338
| -34% | -$78.8K | 0.3% | 60 |
|
|
2026
Q1 | $242K | Buy |
+988
| New | +$230K | 0.48% | 23 |
|
|
2025
Q4 | – | Sell |
-29,010
| Closed | -$5.38M | – | 30 |
|
|
2025
Q3 | $5.38M | Hold |
29,010
| – | – | 1.86% | 9 |
|
|
2025
Q2 | $4.43M | Buy |
29,010
+2,882
| +11% | +$443K | 1.63% | 34 |
|
|
2025
Q1 | $4.33M | Buy |
26,128
+18,641
| +249% | +$2.92M | 1.7% | 29 |
|
|
2024
Q4 | $1.08M | Sell |
7,487
-19,193
| -72% | -$2.97M | 0.42% | 54 |
|
|
2024
Q3 | $4.32M | Buy |
26,680
+5,334
| +25% | +$850K | 1.69% | 23 |
|
|
2024
Q2 | $3.12M | Buy |
21,346
+2,423
| +13% | +$360K | 1.55% | 46 |
|
|
2024
Q1 | $2.99M | Buy |
18,923
+4,930
| +35% | +$785K | 1.52% | 43 |
|
|
2023
Q4 | $2.19M | Sell |
13,993
-4,810
| -26% | -$738K | 0.63% | 54 |
|
|
2023
Q3 | $2.93M | Buy |
18,803
+1,268
| +7% | +$209K | 1.2% | 18 |
|
|
2023
Q2 | $2.9M | Buy |
17,535
+995
| +6% | +$161K | 0.45% | 24 |
|
|
2023
Q1 | $2.56M | Sell |
16,540
-202
| -1% | -$32.6K | 0.36% | 22 |
|
|
2022
Q4 | $2.96M | Buy |
16,742
+116
| +0.7% | +$20K | 0.47% | 20 |
|
|
2022
Q3 | $2.72M | Buy |
16,626
+851
| +5% | +$144K | 1.09% | 19 |
|
|
2022
Q2 | $2.8M | Sell |
15,775
-1,750
| -10% | -$312K | 0.93% | 19 |
|
|
2022
Q1 | $3.11M | Sell |
17,525
-2,191
| -11% | -$373K | 0.88% | 20 |
|
|
2021
Q4 | $3.37M | Buy |
19,716
+1,308
| +7% | +$214K | 0.91% | 21 |
|
|
2021
Q3 | $2.97M | Buy |
18,408
+1,956
| +12% | +$334K | 0.86% | 27 |
|
|
2021
Q2 | $2.71M | Buy |
16,452
+1,631
| +11% | +$270K | 0.94% | 26 |
|
|
2021
Q1 | $2.44M | Buy |
14,821
+2,699
| +22% | +$437K | 0.89% | 24 |
|
|
2020
Q4 | $1.91M | Buy |
12,122
+2,144
| +21% | +$316K | 0.88% | 25 |
|
|
2020
Q3 | $1.49M | Buy |
9,978
+73
| +0.7% | +$10.8K | 0.81% | 31 |
|
|
2020
Q2 | $1.39M | Buy |
9,905
+1,065
| +12% | +$155K | 0.78% | 33 |
|
|
2020
Q1 | $1.16M | Buy |
8,840
+6,050
| +217% | +$858K | 0.6% | 31 |
|
|
2019
Q4 | $407K | Buy |
2,790
+80
| +3% | +$10.9K | 0.25% | 35 |
|
|
2019
Q3 | $351K | Sell |
2,710
-5,976
| -69% | -$787K | 0.22% | 32 |
|
|
2019
Q2 | $1.21M | Buy |
8,686
+6,226
| +253% | +$862K | 0.54% | 39 |
|
|
2019
Q1 | $344K | Sell |
2,460
-5,940
| -71% | -$796K | 0.25% | 35 |
|
|
2018
Q4 | $1.08M | Buy |
8,400
+245
| +3% | +$34.2K | 0.71% | 27 |
|
|
2018
Q3 | $1.13M | Hold |
8,155
| – | – | 0.79% | 28 |
|
|
2018
Q2 | $990K | Sell |
8,155
-14
| -0.2% | -$1.75K | 0.94% | 25 |
|
|
2018
Q1 | $1.05M | Buy |
8,169
+814
| +11% | +$110K | 0.99% | 23 |
|
|
2017
Q4 | $1.03M | Buy |
+7,355
| New | +$1.02M | 1.06% | 27 |
|
Other funds holding JNJ
PAM
WT
FWIA
DC
CF
Arlington Partners's JNJ Position: Q2 2026 in Review
Arlington Partners reduced its Johnson & Johnson (JNJ) stake by 34% in Q2 2026, selling an estimated $78.8K and leaving 650 shares worth $165K. The position accounts for 0.3% of the portfolio, ranked #60.
Arlington Partners first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. The position peaked at $5.38M in Q3 2025. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Arlington Partners held 650 shares of Johnson & Johnson worth $165K as of Q2 2026.
- Arlington Partners sold 338 Johnson & Johnson shares in Q2 2026, an estimated $78.8K.
- Johnson & Johnson made up 0.3% of Arlington Partners's portfolio in Q2 2026, its #60 holding.
- Arlington Partners first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
- Arlington Partners's Johnson & Johnson position peaked at $5.38M in Q3 2025.
- 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Arlington Partners's 13F filing for Q2 2026, filed 7 Jul 2026.